Hu Yiduo, Petit Sarah A, Ficarro Scott B, Toomire Kimberly J, Xie Anyong, Lim Elgene, Cao Shiliang A, Park Eunyoung, Eck Michael J, Scully Ralph, Brown Myles, Marto Jarrod A, Livingston David M
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Genetics, Harvard Medical School, Boston, Massachusetts. Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. Department of Genetics, Harvard Medical School, Boston, Massachusetts.
Cancer Discov. 2014 Dec;4(12):1430-47. doi: 10.1158/2159-8290.CD-13-0891. Epub 2014 Sep 24.
BRCA1 promotes homologous recombination-mediated DNA repair (HRR). However, HRR must be tightly regulated to prevent illegitimate recombination. We previously found that BRCA1 HRR function is regulated by the RAP80 complex, but the mechanism was unclear. We have now observed that PARP1 interacts with and poly-ADP-ribosylates (aka PARsylates) BRCA1. PARsylation is directed at the BRCA1 DNA binding domain and downmodulates its function. Moreover, RAP80 contains a poly-ADP-ribose-interacting domain that binds PARsylated BRCA1 and helps to maintain the stability of PARP1-BRCA1-RAP80 complexes. BRCA1 PARsylation is a key step in BRCA1 HRR control. When BRCA1 PARsylation is defective, it gives rise to excessive HRR and manifestations of genome instability. BRCA1 PARsylation and/or RAP80 expression is defective in a subset of sporadic breast cancer cell lines and patient-derived tumor xenograft models. These observations are consistent with the possibility that such defects, when chronic, contribute to tumor development in BRCA1+/+ individuals.
We propose a model that describes how BRCA1 functions to both support and restrict HRR. BRCA1 PARsylation is a key event in this process, failure of which triggers hyper-recombination and chromosome instability. Thus, hyperfunctioning BRCA1 can elicit genomic abnormalities similar to those observed in the absence of certain BRCA1 functions.
BRCA1促进同源重组介导的DNA修复(HRR)。然而,HRR必须受到严格调控以防止非法重组。我们之前发现BRCA1的HRR功能受RAP80复合体调控,但机制尚不清楚。我们现在观察到PARP1与BRCA1相互作用并使其发生多聚ADP核糖基化(即PAR化)。PAR化作用于BRCA1的DNA结合结构域并下调其功能。此外,RAP80含有一个多聚ADP核糖相互作用结构域,可结合PAR化的BRCA1并有助于维持PARP1 - BRCA1 - RAP80复合体的稳定性。BRCA1的PAR化是BRCA1 HRR调控的关键步骤。当BRCA1的PAR化存在缺陷时,会导致过度的HRR和基因组不稳定的表现。在一部分散发性乳腺癌细胞系和患者来源的肿瘤异种移植模型中,BRCA1的PAR化和/或RAP80的表达存在缺陷。这些观察结果与以下可能性一致,即当这些缺陷长期存在时,会促进BRCA1+/+个体的肿瘤发展。
我们提出了一个模型,描述了BRCA1如何发挥作用来支持和限制HRR。BRCA1的PAR化是这一过程中的关键事件,其失败会引发过度重组和染色体不稳定。因此,功能亢进的BRCA1可引发类似于在缺乏某些BRCA1功能时所观察到的基因组异常。